MILTON, N.Y.--(BUSINESS WIRE)--Sono-Tek Corporation (OTCQX:SOTK) the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its fourth quarter and fiscal year ended February 28, 2018 (“fiscal 2018”).
“We had excellent growth trends through the year. Strong market conditions combined with the expansion of our sales effort drove sales up 14% to $11.0 million,” commented Dr. Christopher L. Coccio, Chairman and CEO. “Additionally, the strong operating leverage inherent in our business was evident in our measurable margin expansion.”
Dr. Coccio added, “We believe our continued implementation of LEAN manufacturing practices this past year were apparent in our strong cash generation. Our productivity focus has resulted in a significant reduction in inventory requirements and is also increasingly contributing to improved operating efficiencies and cycle time reduction.”
Cash and cash equivalents increased $1.5 million to $6.4 million, even as we continued to invest in engineering as well as product and market development.”
Dr. Coccio concluded, “Based on our current backlog, shipments, and proposals, we expect stronger sales in the first quarter of fiscal 2019 compared with last year’s first quarter. In fact, we anticipate solid growth in revenue for fiscal year 2019 from our new products and applications, supported by the strong global economy and fiscal improvements in the U.S.”
Fiscal 2018 Review ($’s in thousands, except per share data)
|Fiscal Year Ended|
|Operating Income (Loss)||$382||($179)||$560||-|
|Net Income (Loss)||$368||$96||$273||284.7%|
|Basic Earnings Per Share||$0.02||$0.01|
|Diluted Earnings Per Share||$0.02||$0.01|
|Weighted Average Shares -Basic||14,968,450||14,961,076|
|Weighted Average Shares - Diluted||15,095,123||15,018,282|
The increase in net sales reflects higher volume in Multi-Axis Systems and Integrated Coating Systems due in large part to growth in the medical and alternative energy markets, the latter being led by fuel cell development programs in China. Higher sales to the medical industry was the result of specialized application expertise for polymer and other active nanomaterial coatings on implantable devices.
In fiscal 2018, approximately 56% of sales originated outside of the United States and Canada. This compares with 60% in fiscal 2017. The geographic shift was mostly because of higher sales to the U.S. medical market.
Gross margin was up 280 basis points primarily due to product mix, as a greater portion of the sales growth was from higher margin Multi-Axis Systems and Integrated Coating Systems. In addition, fixed overhead costs were marginally down during the fiscal year.
The Company continued to invest in new product development and sales and marketing as it addressed market expansion opportunities. However, with strong sales growth, as a percentage of net sales, operating expenses were down 250 basis points to 44.6%. As a result, operating margin improved to 3.5%.
Sono-Tek achieved net income of $0.4 million, or $0.02 per basic and diluted share, up $0.01 from the prior year.
Fourth Quarter Fiscal 2018 Review ($’s in thousands except per share data)
|Three Months Ended|
|Operating Income (Loss)||$94||$29||$65||224%|
|Net Income (Loss)||$103||$67||$36||54%|
|Basic Earnings Per Share||$0.01||$0.00|
|Diluted Earnings Per Share||$0.01||$0.00|
|Weighted Average Shares - Basic||14,981,902||14,961,076|
|Weighted Average Shares - Diluted||15,181,331||15,058,366|
Balance Sheet and Cash Flow Overview
Net cash provided by operating activities was $1.8 million, up $0.8 million, or 75%. Capital expenditures were $0.2 million for fiscal 2018, consistent with the prior-year period, primarily for the purchase or manufacture of equipment, furnishings and leasehold improvements. The Company anticipates total capital expenditures to be approximately $0.4 million to $0.6 million in fiscal 2019.
At February 28, 2018, the Company had total debt of $1.0 million, down $150 thousand since fiscal 2017 year-end. Sono-Tek has a revolving credit line of $750 thousand and a $250 thousand equipment purchase facility, both of which had no outstanding borrowings at year-end.
Sono-Tek Corporation is the leading developer and manufacturer of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive.
The Company’s solutions are environmentally-friendly, efficient and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.
Sono-Tek’s growth strategy is focused on leveraging its innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop microscopic coating technologies that enable better outcomes for its customers’ products and processes.
For further information, visit www.sono-tek.com.
Safe Harbor Statement
This news release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; timely development and market acceptance of new products; adequacy of financing; capacity additions; the ability to enforce patents; maintenance of operating leverage; continued reduction in inventory requirements; maintenance of order backlog; consummation of order proposals; continued sales growth in the medical and alternative energy markets; and the ability to achieve increased sales volume at projected levels and continued profitability. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-K and Form 10-Qs containing additional important information.
|Cash and cash equivalents||$||2,016,464||$||2,557,223|
|Accounts receivable (less allowance of $46,000)||774,778||1,150,801|
|Prepaid expenses and other current assets||139,406||127,276|
|Total current assets||8,690,631||7,518,168|
|Equipment, furnishings and leasehold improvements, net||498,401||624,197|
|Intangible assets, net||136,576||153,326|
|Deferred tax asset||396,387||315,171|
|LIABILITIES AND STOCKHOLDERS’ EQUITY|
|Current maturities of long term debt||156,119||149,698|
|Income taxes payable||84,621||14,619|
|Total current liabilities||2,130,893||1,448,535|
|Deferred tax liability||385,384||337,726|
|Long term debt, less current maturities||870,532||1,026,650|
|Commitments and Contingencies||-||-|
|Common stock, $.01 par value; 25,000,000 shares authorized, 14,986,367 and 14,961,076 issued and outstanding, respectively||149,864||149,611|
|Additional paid-in capital||8,901,171||8,859,486|
|Accumulated other comprehensive income||101,605||42,250|
|Total stockholders’ equity||8,392,525||7,923,025|
|TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY||$||11,779,334||$||10,735,936|
|Fiscal Year Ended|
|Cost of Goods Sold||5,711,951||5,272,050|
|Research and product development||1,280,308||1,275,902|
|Marketing and selling||2,516,461||2,217,218|
|General and administrative||1,118,107||1,048,407|
|Total Operating Expenses||4,914,876||4,541,527|
|Operating Income (Loss)||381,617||(178,621||)|
|Other Income (Expense):|
|Interest and Dividend Income||91,459||70,797|
|Income before Income Taxes||460,063||76,332|
|Income Tax (Benefit) Expense||91,856||(19,374||)|
|Other Comprehensive Income|
|Net unrealized gain on marketable securities||59,355||112,390|
|Basic Earnings Per Share||$||.02||$||.01|
|Diluted Earnings Per Share||$||.02||$||.01|
|Weighted Average Shares – Basic||14,968,450||14,961,076|
|Weighted Average Shares – Diluted||15,095,123||15,018,282|
|Fiscal Year Ended|
|CASH FLOWS FROM OPERATING ACTIVITIES:|
|Adjustments to reconcile net income to net|
|cash provided by operating activities:|
|Depreciation and amortization||399,526||440,223|
|Stock based compensation expense||41,728||47,319|
|Deferred tax expense||(33,558||)||5,750|
|(Increase) Decrease in:|
|Prepaid expenses and other assets||(12,130||)||(17,322||)|
|(Decrease) Increase in:|
|Accounts payable and accrued expenses||340,739||(16,017||)|
|Income taxes payable||70,002||(73,041||)|
|Net Cash Provided by Operating Activities||1,802,334||1,028,653|
|CASH FLOWS FROM INVESTING ACTIVITIES:|
|Purchase of equipment, furnishings and leasehold improvements||(189,245||)||(182,837||)|
|(Purchase) of marketable securities||(2,004,360||)||(533,559||)|
|Net Cash (Used In) Investing Activities||(2,193,605||)||(716,396||)|
|CASH FLOWS FROM FINANCING ACTIVITIES:|
|Proceeds from exercise of options||210||-|
|Repayment of long term debt||(149,698||)||(143,389||)|
|Net Cash (Used In) Financing Activities||(149,488||)||(143,389||)|
|NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS||(540,759||)||168,868|
|CASH AND CASH EQUIVALENTS:|
|Beginning of year||2,557,223||2,388,355|
|End of year||$||2,016,464||$||2,557,223|
|Supplemental Cash Flow Disclosure:|
|Income Taxes Paid||$||59,494||$||56,502|